Scarica l'app Stockscreener
3.1301
1.62%
0.0501
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.08
Aprire:
$3.12
Volume 24 ore:
327.25K
Relative Volume:
0.30
Capitalizzazione di mercato:
$159.96M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-2.8199
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-0.95%
1M Prestazione:
+1.62%
6M Prestazione:
+43.58%
1 anno Prestazione:
-37.40%
Intervallo 1D:
$3.09
$3.17
Intervallo di 1 settimana:
$3.08
$3.475
Portata 52W:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
3.13 | 157.40M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.18 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.65 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
808.25 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-21 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2024-09-27 | Iniziato | Raymond James | Strong Buy |
| 2023-05-10 | Reiterato | Maxim Group | Buy |
| 2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
What momentum shifts mean for Achieve Life Sciences Inc.July 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Relative strength of Achieve Life Sciences Inc. in sector analysisWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Price momentum metrics for Achieve Life Sciences Inc. explained2025 Retail Activity & Target Return Focused Stock Picks - newser.com
What machine learning models say about Achieve Life Sciences Inc.Volume Spike & AI Driven Price Forecasts - newser.com
Is Achieve Life Sciences Inc. meeting your algorithmic filter criteria2025 Top Decliners & Daily Entry Point Alerts - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
Using R and stats models for Achieve Life Sciences Inc. forecasting2025 Price Targets & AI Enhanced Trading Signals - newser.com
Using data models to predict Achieve Life Sciences Inc. stock movementMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
How Achieve Life Sciences Inc. (SP4P) stock stacks up against competitorsJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
Is Achieve Life Sciences Inc a good long term investmentEarnings Call Summaries & Predict Volatility With Our Neural Network - earlytimes.in
What to expect from Achieve Life Sciences Inc. in the next 30 daysJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
What earnings revisions data tells us about Achieve Life Sciences Inc.July 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year - simplywall.st
How forex fluctuations impact Achieve Life Sciences Inc. (SP4P) stockJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Achieve Life Sciences' (ACHV) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Achieve Life Sciences Announces Leadership Change - TipRanks
Achieve Life Sciences announces resignation of chief medical officer and president - Investing.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Using AI based signals to follow Achieve Life Sciences Inc.2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock stage a strong rebound this quarterDollar Strength & Community Supported Trade Ideas - newser.com
Understanding Achieve Life Sciences Inc.’s price movementEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
How Achieve Life Sciences Inc. (SP4P) stock compares with top peersMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
How to use Fibonacci retracement on Achieve Life Sciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - newser.com
Custom strategy builders for tracking Achieve Life Sciences Inc.Market Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Published on: 2025-10-02 18:42:53 - newser.com
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewswire
161,000-Share Option Grant: Achieve Life Sciences Awards to 5 New Hires — 10‑Year Term, 25% Vests After 1 Year - Stock Titan
Published on: 2025-10-01 06:37:19 - newser.com
Achieve Life Sciences: Promising Pipeline But High Risks Makes Me Hold For Now (NASDAQ:ACHV) - Seeking Alpha
Is Achieve Life Sciences Inc SP4P a good long term investmentStock Price Divergence & Outstanding Profit Strategies - earlytimes.in
Is Achieve Life Sciences Inc. stock supported by strong fundamentalsWeekly Trend Report & Safe Capital Growth Stock Tips - newser.com
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):